NCT02892942View on ClinicalTrials.gov

NATural Ovarian Stimulation

PHASE4CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

January 13, 2017

Primary Completion Date

February 8, 2019

Study Completion Date

February 8, 2019

Conditions
Infertility
Interventions
DRUG

Gonal-F®

225 to 450 IU/d; from day 2 of menstrual cycle onward

DRUG

Cetrotide®

0.25 mg/day, starting on day 6 of Gonal-F®.

DRUG

Cetrotide®

1.5 mg/day (6 ampoules of 0.25 mg), starting on day 1 (S1) of Gonal-F® treatment until dhCG

Trial Locations (1)

92141

Hôpital Antoine Béclère, Clamart

Sponsors
All Listed Sponsors
collaborator

MerckSerono Pharmaceuticals

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER